Fig. 1From: Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort studyFlowchart of included patients. ADA: adalimumab, ETN: etanercept, JAMAR: juvenile arthritis multidimensional assessment report, JIA: juvenile idiopathic arthritisBack to article page